Company Presentation

LimmaTech Biologics AG

Category:Emerging Biotech Company
Date:April 24, 2023
Speaker:Patricia Martin, PhD, Managing Director and Vice President Clinical and Regulatory Affairs

Company profile

LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We apply our deep expertise in engineering complex carbohydrate molecules to develop next-generation vaccines to prevent life-threatening diseases. Our proprietary vaccine pipeline is focused on halting the increasing threat of global infections due to antimicrobial resistance (AMR) and sexually transmitted diseases. We also develop vaccines with our partner, GSK.

Follow us